Capabilities
More than three hundred and fifty King & Spalding lawyers across our litigation, transactional and regulatory teams devote all or a substantial portion of their practice to serving clients in every segment of the Life Sciences and Healthcare sectors.
The comprehensive scope of the practice is unique: from helping to establish the start-ups developing the latest breakthrough drugs and medical devices, to defending the world’s largest pharmaceutical manufacturers in precedent-setting legal challenges, to representing major healthcare systems on their thorniest Medicare/Medicaid litigation or their strategic acquisitions, to counseling on the full spectrum of regulatory matters that these diverse entities face. We fully leverage our ability to draw on our broad experience as we work together to achieve outcomes that best protect and advance the interests of our clients across these sectors.
The lawyers in this group bring exceptionally deep industry and technical knowledge, many with advanced degrees in life sciences and medical fields as well as professional experience as scientists, surgeons, engineers, in-house lawyers and executives, senior regulators at the FDA, HHS and CMS, and enforcement officials at the DOJ.
Life Sciences
Named a four time winner of Law 360’s “Practice Group of the Year” (2016-2019), the firm currently represents more than 250 pharmaceutical, biotechnology and medical device manufacturers, including eight of the top 10 pharmaceutical/biotechnology manufacturers and eight of the top 10 medical device manufacturers. We offer clients our unique perspective at every stage of the product life cycle — from emerging growth company counseling on intellectual property, capital-raising transactions, license and corporate partnering agreements, and clinical trials, through FDA approval, manufacturing, marketing, commercial and post-approval regulatory, strategic M&A, and other corporate transactions, to litigation and government and internal investigation matters. Our government affairs lawyers also help our clients in the industry understand and navigate legislative and regulatory developments in Washington, D.C., and in state capitals across the country.
Healthcare
The firm has one of the largest practices in the U.S., representing organizations involved in the delivery of healthcare services and products across all facets of the legal issues they face. We serve the entire spectrum of healthcare institutional providers, practitioners, payors, educators, researchers, inventors, suppliers, investors and manufacturers across the nation.
Alex is a nationally recognized trial lawyer who has obtained countless successful verdicts on behalf of companies in the pharmaceutical, medical device and toxic tort sectors in multi-district litigation and statewide coordinated proceedings.
Read More
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Technology Industry
January 21, 2021
General Counsel Internal Investigations Decision Tree for the Financial Services Industry
January 15, 2021
Legal 500 Deutschland 2021 Ranks King & Spalding Among Germany’s Leading Law Firms
January 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
November 24, 2020
IAM Magazine Recognizes Holmes Hawkins, Gerald Flattmann in 2021 Global Leaders Guide